Active Biomarkers

Active Biomarkers est membre de Lyonbiopôle

General information

Bâtiment Domilyon - 321, avenue Jean Jaurès

69007 Lyon

Incorporated in: 2011/04/01

Number of employees: 29

Turnover: €3M (in 2019)

 

Main activity

Founded in 2011, Active Biomarkers (formerly ABL Immuno) is an integrated bioanalytical laboratory offering multiple in-vitro immunology services, including soluble and cellular biomarker analyses for clinical studies. Operating in BSL2 facilities, and GCLP/ISO 9001:2015 environment, the company currently employs 30 people bringing a wealth of experience in the development, validation, and implementation of analytical methods. Its know-how is recognised in 4 major therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. Beyond its state-of-the-art flow cytometry and ELISpot capabilities, Active Biomarkers offers the broadest panel of immunoassay technologies in Europe, ranging from standard ELISA to multiplexed methods such as Luminex, SP-X, Gyros or ELLA systems, and ultra-sensitive technologies such as MSD or Simoa HD-1. For more information on our biomarker and immune monitoring services, please contact us at: info@active-biomarkers.com

Segmentation
Activities
Products / Services / Technologies

Strategic area of application
Human Medicine


Application market
Immune, AutoIm & Inflam. diseases - Neurological diseases - Oncology


Activities
Diagnostics - CRO


Technologies
Analytical & Diagnostic services - Cell Therapy - cell biology - Biobanking - Antibodies - Protein - Peptide